APA (7th ed.) Citation

Han, J., Ahn, M., Lee, K. H., Lee, Y., Kim, D., Min, Y. J., . . . Cho, B. C. (2024, October). Updated overall survival and ctDNA analysis in patients with EGFR T790M-positive advanced non-small cell lung cancer treated with lazertinib in the phase 1/2 LASER201 study. BMC Medicine.

Chicago Style (17th ed.) Citation

Han, Ji-Youn, et al. "Updated Overall Survival and CtDNA Analysis in Patients with EGFR T790M-positive Advanced Non-small Cell Lung Cancer Treated with Lazertinib in the Phase 1/2 LASER201 Study." BMC Medicine Oct. 2024.

MLA (9th ed.) Citation

Han, Ji-Youn, et al. "Updated Overall Survival and CtDNA Analysis in Patients with EGFR T790M-positive Advanced Non-small Cell Lung Cancer Treated with Lazertinib in the Phase 1/2 LASER201 Study." BMC Medicine, Oct. 2024.